Conversely, the incidence, multiplicity and burden of cSCC that form in Keap1-knockdown mice that are also deficient for NRF2 are much greater than in their Keap1-knockdown/NRF2-proficient counterparts, establishing NRF2 activation as the protection mediator [139]. This evidence concerns the gene NFE2L2 and skin squamous cell carcinoma.